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New Delhi, IndiaTobacco consumption, in the past few decades
has arguably been established as one of the most
significant preventable causes of mortality and mor-
bidity globally [1]. Recent projections estimate that
tobacco kills at least 6 million people globally every
year, which is much higher than the combined
mortality caused by diseases such as acquired
immunodeficiency syndrome, tuberculosis, and ma-
laria [2]. The low- and middle-income countries
(LMICs) are the worst affected by the tobacco epi-
demic [2]. It is estimated that by 2030, more than
80% of the tobacco-related deaths will occur in
LMICs [3].
Tobacco use is a leading preventable risk factor
of cardiovascular diseases (CVDs) [4]. About 1.62
billion deaths in the year 2000 (1 in every 10 car-
diovascular deaths) worldwide were due to smoking
tobacco in any form [5]. Approximately one-third
of deaths due to tobacco are likely to be attributed
to CVDs by the year 2015 [6].
Understanding the historical evolution of tobac-
co use and its association with CVDs may stimulate
as well as provide important inputs for future tobac-
co control and CVD prevention programs and
policies.TOBACCO ’ S J OURNEY ACROS S TH E
WOR LD
The story of the origin and spread of tobacco goes
back thousands of years. The tobacco plant is
mostly indigenous to the Americas, where its culti-
vation was started by the native Indians in the year
6000 BCE [1]. Tobacco was introduced in Europe
in 1492 when Christopher Columbus and his crew
returned from their first voyage of the Americas andFrom the Public Health Foundation of India, New Delhi, India; Cen
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From Europe, tobacco spread to other parts of the
world in the 16th century. In the early 16th century,
tobacco was introduced in the Middle East by
Egyptians [8]. Tobacco was introduced in China
and Japan between 1530 and 1600, and the Japa-
nese army introduced tobacco in Korea in the last
decade of the 16th century [7]. During the same
period, Portuguese and Spanish traders took tobac-
co to Africa during their voyages [7]. The Portu-
guese brought tobacco to India in early parts of
the 17th century where they used tobacco leaves
as barter for spices and textiles [1].
The origin of the word tobacco is contested.
Some people believe that it is derived from the Ara-
bic word tabaq, which means ‘‘euphoria producing
herb.’’ Some experts believe that tobacco comes
from the Caribbean word tabaco, which is the name
of the pipe from which tobacco was smoked. Some
sources refer the origin of this word from the
Tabasco state in Mexico [9]. The tobacco plant
was botanically named by Swedish botanist Carolus
Linnaeus in 1753. He described 2 species of the to-
bacco plant: nicotiana rustica and nicotiana tabacum.
He named the tobacco plant after French Diplomat
Jean Nicot who introduced and popularized tobacco
in France as a cure for migraine headaches [1].
Historically, tobacco has been used for several
purposes. These varied from time to time and re-
gion to region. Tobacco was mainly used by Native
Americans for ceremonial purposes. They used to-
bacco for smoking, ingesting orally as syrup and
chewing [8]. They even consumed tobacco through
rectal enemas in a spiritual ritual [8]. In Haiti, to-
bacco was used as a medicine for cleaning nasal pas-
sages and as an analgesic [1]. In the 16th century,
European doctors used to recommend tobacco astre for Cardiometabolic Risk Reduction in South Asia, Public Health
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lockjaw, halitosis, worms, and cancer [10]. The rec-
reational use of tobacco started in the latter half of
the 16th century when pipe smoking was popular-
ized by Thomas Harriot (on his return from Vir-
ginia, where he was sent to explore opportunities
in the newly acquired colony) and his friend Sir
Walter Raleigh (an English aristocrat, who devel-
oped the art of curing tobacco leaves in a way that
popularized smoking among the British aristoc-
racy) [10]. In the beginning of the 17th century,
pipe smoking became popular in the Netherlands
and later in the 18th and 19th centuries, it spread
across Europe and to the East Asian countries
[10]. In India and the Middle East, hookah or
water pipe smoking (where tobacco smoke was fil-
tered through water to overcome its purported ill
effects) was popular among noble and elite classes
[11]. Oral and nasal forms of tobacco use became
popular in the 18th century [12]. In India, chewing
of different flavors of tobacco flakes along with be-
tel quid gained popularity especially among wo-
men. Women, in those times used to color their
lips and mouth red by chewing tobacco with betel
quid for makeup. Sniffing tobacco was also widely
accepted, which led to an increase in import of to-
bacco in India during the Medieval Ages [11].
During the Crimean War, the use of cigarettes
started becoming popular [10]. Consumption of
cigarettes increased exponentially during World
War I and by the end of World War II, cigarette
smoking was the most common form of tobacco
consumption in developed countries of the world
[10]. Cigarette smoking became deeply ingrained
in Western society after World War II. Cigarette
smoking remains the most popular means of tobac-
co consumption worldwide.TOBACCO CONSUMPT I ON AND CVDS :
T H E H I S TOR I C A L E V I D ENC E
Huchard [13], in his article on diseases of the heart
and blood vessels in the year 1893, provided some
of the first evidence in scientific literature of a rela-
tionship between tobacco consumption and heart
diseases. He wrote: ‘‘The (unfavorable) influences
of nicotinism on the development of arteriosclero-
sis appear to have been demonstrated. And this is
not surprising since nicotine produces most often
arterial hypertension by vasoconstriction’’ [13].
Since the early 20th century, several physicians
and researchers have implicated tobacco in increas-
ing the risk of several CVDs. Erb [14], in 1904,found that almost 60% of patients with intermit-
tent claudication were heavy smokers. Buerger
[15], in 1908, reported a rare form of peripheral
vascular disease that leads to progressive inflamma-
tion and thrombosis of arteries and veins of hand
and feet and occurs mostly in smokers. This disease
was later named after him as Buerger’s disease
(thromboangiitis obliterans). His findings were sup-
ported by Weber [16], Brown and Allen [17],
and Allen et al. [18]. Hoffman was among the first
to show a statistical association between smoking
and coronary thrombosis [19]. English et al. [20]
compared 1,000 smokers matched with 1,000 non-
smokers in 1940 to show possible association be-
tween smoking and CVDs and concluded that
there is ‘‘a more profound effect on younger indi-
viduals owing to the existence of relatively normal
cardiovascular systems, influencing perhaps the ear-
lier development of coronary disease.’’ The first
U.S. Surgeon General’s Report on Smoking and
Health [21] provided evidence of higher death
rates among male smokers from coronary artery
disease in comparison to male nonsmokers. This
evidence was further strengthened in the U.S. Sur-
geon General’s Report of 1971, which stated that
smoking not only is an independent risk factor,
but also combines with other risk factors to affect
cardiovascular health [22]. Hammond [23], in his
study on approximately 1 million people, showed
an increased mortality from coronary heart disease
among cigarette smokers.
The seminal British physicians cohort study by
Doll and Hill [24] showed that male cigarette-
smoking doctors had a higher risk of death from
coronary thrombosis (ratio of death rate for male
smokers in comparison to lifelong nonsmokers un-
der 70 years of age was 2:1 and for men over 70 years
was 5:1). The Framingham Heart Study, which is
one of the most important cohort studies for CVD
epidemiology, in the year 1960, provided evidence
that cigarette smoking increased the risk of heart
disease. The same cohort, in 1988, provided conclu-
sive evidence for cigarette smoking being among the
most important factors to cause stroke [25].ANT I TOBACCO MOVEMENT S AND
S EN T IM ENT S : A H I S TOR I C A L SNAP SHOT
During the time when tobacco consumption was
gaining popularity worldwide the health, societal,
and economic harms of tobacco were also being
highlighted by various scientists, thinkers, and
philosophers.
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109In the year 1604, King James I of England
wrote ‘‘A Counterblaste to Tobacco’’ in which he
said: ‘‘Smoking is a custom loathsome to the eye,
hateful to the nose, harmful to the brain, dangerous
to the lungs, and in the black, stinking fume there-
of nearest resembling the horrible Stygian smoke of
the pit that is bottomless’’ [10].
The first recorded legislation against tobacco
use dates back to 1575, when the Roman Catholic
Church passed a law prohibiting smoking in any
place of worship throughout the Spanish colonies
[26]. In the year 1624, Pope Urban VIII issued a
worldwide ban on using or carrying tobacco prod-
ucts in any place of worship. He also issued a warn-
ing to excommunicate those who violated this law.
However, the law was abolished by Pope Benedict
XIII in the late 17th century who was a tobacco
user himself [10].
From the 17th century onward, different rulers
and religious leaders worldwide have imposed some
form of tobacco ban in their regimes or among
their followers. Sultan Murad IV of the Ottoman
Empire and Czar Michael of Russia issued smok-
ing bans with violators being treated as criminals
and issued a death penalty [7]. In 1891, Iranians,
led by the Grand Ayatollah Haji Mirza Hasan
Shirazi, banned the trading of any tobacco prod-
ucts [7]. Cigarette trading was also banned for
about 26 years in North Dakota [8]. In the latter
half of the 20th century, the tobacco industry be-
came so powerful financially that it started provid-
ing financial assistance to the governments and so
all the existing smoking bans either were made very
weak or were abolished.
One of the most successful antitobacco cam-
paigns took place in Germany and was led by the
Association against Tobacco for the protection of
Non Smokers (Deutscher Tabakgegnerverein zum
Schutze fur Nichtraucher), which was formed in
1904 and rose to strength with the National Socia-
list Party of Germany coming to power in the
1930s [27]. Hitler was strongly against the use of
tobacco and made education about the harmful ef-
fects of tobacco compulsory in junior schools [27].
The government printed pamphlets warning peo-
ple against the harms of tobacco and doctors orga-
nized mass meetings to raise public awareness.
Smoking by uniformed police officers, persons un-
der 18 years of age, and in buses and trains was
banned [27]. However, this campaign against to-
bacco was short-lived and had very little impact
on the per capita consumption of cigarettes, which
rose year after year.E VO LU T I ON OF ANT I TOBACCO
PO L I C I E S I N TH E MODERN ERA
Countries worldwide are now cognizant of the
harmful effects of tobacco, and the ever-powerful
tobacco industry, and are trying to put in place
comprehensive legislations to reduce tobacco
consumption as well as to prevent people who are
nonsmokers from secondhand smoke. California
was the first U.S. state to pass legislation against
smoking in public places, including bars and res-
taurants, in the year 1998 [28]. This was followed
by South Africa, where a law was passed making
public places smoke-free but this law exempted
bars and restaurants from being smoke-free [28].
Ireland was the first country to adopt a comprehen-
sive smoking ban in indoor workplaces, including
bars, pubs, and restaurants. This ban was strength-
ened by overwhelming public support and was seen
as a societal revolution in a country known for its
smoke-filled pubs and restaurants [29]. New
Zealand followed the Irish model of a smoking
ban and became smoke-free in 2005 [28]. Soon
after, a number of European countries such as
Scotland, England, France, and Italy adopted the
legislation of smoke-free indoor areas [8]. The
smoking bans were not confined to European na-
tions and recently Canada and Australia have also
put into effect legislations banning smoking in in-
door areas [8]. India has also been a world leader in
tobacco control. On October 2, 2008, the Indian
government implemented Section 4 of the Ciga-
rette and Other Tobacco Products Act (COTPA),
which banned smoking any form of tobacco in
public places [30]. Although COTPA-2003 is
comprehensive tobacco control legislation, its
implementation has been weak. This has been
mainly due to lack of human resources at the state
level, lack of infrastructure and training to imple-
ment the law, and absence of a strategic media
and communication plan to effectively disseminate
the law.
Given the importance of tobacco control in
reducing CVD burden, the World Health Organi-
zation (WHO) proposed one of the most rapidly
embraced treaties of all time known as the Frame-
work Convention of Tobacco Control (FCTC).
This was the world’s first global public health
treaty, and it came into effect on February 27,
2005 (Table 1). To date, 170 of the 192 members
of WHO have signed and ratified this treaty [8].
The treaty has been immensely successful in
mobilizing resources; it has rallied hundreds of
Table 1. Main provisions of WHO Framework Convention of Tobacco Control
Regulation of:
Contents, packaging, and labeling of tobacco products
Sales to and by minors
Illicit trade in tobacco products
Smoking at work and public places
Reduction in consumer demand by:
Price and tax measures
Comprehensive ban on tobacco advertising, promotion, and sponsorship
Education, training, raising public awareness, and assistance with quitting
Protection of environment and health of tobacco workers:
Support for economically viable alternative activities
Research, surveillance, and exchange of information
Support for legislative action to deal with liability
Adapted, with permission, from Shafey et al. [8].
WHO, World Health Organization.
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ernment action, and raised tobacco control aware-
ness. In a further addition to its tobacco-control
efforts, WHO published the MPOWER report
on the global tobacco epidemic in 2008. The
MPOWER report elaborates 6 strategies, recom-
mended by WHO as an entry point to implemen-
tation of the WHO FCTC (Table 2) [31]. The
report is evidence-based and is shown to reduce
the burden of noncommunicable diseases in coun-
tries that have successfully implemented them.
The MPOWER report serves as a guiding docu-
ment especially for LMICs to help them plan
effective tobacco-control strategies.
The historical evidence stated herein clearly
points to the fact that leaders across the globe be-
lieved that by formulating and effectively imple-
menting antismoking policies, health can be
promoted and premature losses of lives and disabil-
ity can be prevented.Table 2. WHO MPOWER strategy
Monitor tobacco use and prevention policies
Protect people from tobacco smoke
Offer help to quit tobacco use
Warn about the dangers of tobacco
Enforce bans on tobacco advertising, promotion, and
sponsorship
Raise taxes on tobacco
Adapted, with permission, from WHO [31].
WHO, World Health Organization.CONC LU S I ON S
The use of tobacco became omnipresent worldwide
within 150 years of Columbus being introduced to
it in the Americas. Tobacco was successfully able to
percolate through the social and cultural texture of
communities in many continents. This assimilation
was facilitated by the perceived medicinal attributes
of tobacco and its ability to suppress hunger and
provide mild intoxication. Myriad varieties of to-
bacco products and methods in which they can be
used made it popular across the globe. Although
there were many controversies against tobacco use
and concerns about health effects of its use, the
demand for tobacco kept expanding across the
world and provided the thrust to tobacco compa-
nies for increased production of tobacco. The ready
revenues that strengthened the economy along with
ease of export and employment opportunities pro-
vided a rationale for bringing tobacco to center
stage both as a crop and as an industry. It is this
amalgamation of international linkages, strong eco-
nomic forces, and distinctive sociocultural influ-
ences that make the history of tobacco a very
fascinating study.
Learning from history, a concerted action is
needed at the international, the national, and the
community levels to curb the tobacco epidemic,
which in turn will help in reducing the burden of
CVDs. The tobacco industry, over the years, has
worked to assimilate tobacco use in culture, political
structures, local and national economies, and
personal behaviors. Therefore, sustainable tobac-
co-control efforts require not only government
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but also effective global health governance to control
the multinational marketing, trade agreements, and
information asymmetry that supports tobacco use.
The history of tobacco helps us to observe mul-
tiple factors and events that have contributed to therise and fall of tobacco consumption worldwide.
The history of tobacco provides a tool for discus-
sion and a move forward for effective tobacco-con-
trol policies to realize the dream of a tobacco-free
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